Results 51 to 60 of about 27,405 (227)

Topics of Interest in Women With Myeloproliferative Neoplasms

American Journal of Hematology, Volume 100, Issue S4, Page 74-87, June 2025.
Women with MPN: life‐cycle phases, specific risks, and influencing factors. ABSTRACT Overview Sex and gender have emerged as central modifiers of disease biology, phenotype, and clinical outcomes in myeloproliferative neoplasms (MPNs). This review will uniquely highlight issues affecting women with MPN and articulate their relevant determinants ...
Natasha Szuber, Paola Guglielmelli, Naseema Gangat   +2 more
wiley   +1 more source

Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease

World Journal of Surgical Oncology, 2020
Recent evidence suggested that secondary surgical cytoreduction followed by chemotherapy does not result in longer overall survival in patients with platinum-sensitive recurrent ovarian cancer.
Juan J. Segura-Sampedro, R. Morales-Soriano, Á. Arjona-Sánchez, P. Cascales-Campos   +3 more
semanticscholar   +1 more source

Residual tumor cells that drive disease relapse after chemotherapy do not have enhanced tumor initiating capacity. [PDF]

, 2012
Although chemotherapy is used to treat most advanced solid tumors, recurrent disease is still the major cause of cancer-related mortality. Cancer stem cells (CSCs) have been the focus of intense research in recent years because they provide a possible ...
de la Cruz, Cecile, Eastham-Anderson, Jeffrey, Hegde, Ganapati V, Jackson, Erica L, Sweet-Cordero, E Alejandro, Zheng, Yanyan   +5 more
core   +2 more sources

The Effect of Postoperative Antithrombin Supplementation on the Inflammatory and Coagulation Status of a Surgically Treated Patient With a Malignant Tumor in the Small Pelvis—Case Series

Cancer Reports, Volume 8, Issue 6, June 2025.
ABSTRACT Introduction Antithrombin has the function of a natural anticoagulant. It is the main component of the inhibitory anticoagulant system, which, under physiological conditions, opposes the procoagulant mechanisms of hemostasis, preventing the occurrence of a hypercoagulable state, the development of thrombosis, and thromboembolic complications ...
Ranko Lazović, Ognjenka Šarenac
wiley   +1 more source

Chemokine Ligand 5 to Predict Optimal Cytoreduction in Ovarian Cancer

International Journal of General Medicine, 2020
Purpose The ultimate goal of cytoreduction surgery is the complete removal of all visible tumors (complete cytoreductive surgery) or tumor residues
Y. Hidayat, Munizar, A. B. Harsono, G. Winarno, Hasanuddin, Siti Salima   +5 more
semanticscholar   +1 more source

Dynamics of the intratumoral immune response during progression of high-grade serous ovarian cancer [PDF]

, 2018
PURPOSE: Tumor-infiltrating lymphocytes (TILs) have an established impact on the prognosis of high-grade serous ovarian carcinoma (HGSOC), however, their role in recurrent ovarian cancer is largely unknown.
Braicu, I, Budczies, J, Castillo-Tong, DC, Darb-Esfahani, S, Denkert, C, Gabra, H, Ganapathi, RN, Gourley, C, Jöhrens, K, Kolaschinski, I, Kreuzinger, C, Kulbe, H, Lambrechts, S, Ruscito, I, Schmitt, W, Sehouli, J, Stanske, M, Vergote, I, Wienert, S   +18 more
core   +4 more sources

Peritoneal carcinomatosis [PDF]

, 2013
Several gastrointestinal and gynecological malignancies have the potential to disseminate and grow in the peritoneal cavity. The occurrence of peritoneal carcinomatosis (PC) has been shown to significantly decrease overall survival in patients with liver
Ansaloni L, BAIOCCHI, Gian Luca, Catena F., Coccolini F, Ghermandi C, GHEZA, Federico, GIULINI, Stefano Maria, Iusco D, Lotti M, Melotti R, Virzì S   +10 more
core   +1 more source

Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD73/anti‐PD‐L1 immunotherapy in arm A of the NSGO‐OV‐UMB1/ENGOT‐OV30 trial

Molecular Oncology, Volume 19, Issue 5, Page 1436-1451, May 2025.
Using mass cytometry, we analyzed serial blood samples from patients with relapsed epithelial ovarian cancer (EOC) treated with oleclumab–durvalumab combination immunotherapy in the NSGO‐OV‐UMB1/ENGOT‐OV30 trial. Our analysis identified potential predictive, monitoring, and response biomarkers detectable through liquid biopsy. These findings facilitate
Luka Tandaric, Annika Auranen, Katrin Kleinmanns, René DePont Christensen, Liv Cecilie Vestrheim Thomsen, Cara Ellen Wogsland, Emmet McCormack, Johanna Mäenpää, Kristine Madsen, Karen Stampe Petersson, Mansoor Raza Mirza, Line Bjørge   +11 more
wiley   +1 more source

Update on imaging of ovarian cancer [PDF]

, 2016
This review will make familiar with new concepts in ovarian cancer and their impact on radiological practice. Disseminated peritoneal spread and ascites are typical of the most common (70–80 %) cancer type, highgrade serous ovarian cancer.
Cunha, Teresa Margarida, Forstner, Rosemarie, Meissnitzer, Matthias   +2 more
core   +1 more source

A Toolkit for Healthcare Transition for Adolescents With Classical Myeloproliferative Neoplasms

Pediatric Blood &Cancer, Volume 72, Issue 5, May 2025.
ABSTRACT Classical myeloproliferative neoplasms (MPNs) are being identified more frequently in adolescents. There is no guidance on the healthcare transition of young MPN patients from pediatric to adult medicine. Therefore, we convened an international panel of experts in both pediatric and adult MPN care to develop three tools to facilitate high ...
Nicole Kucine, Holger Cario, Ghaith Abu‐Zeinah, Maria Caterina Putti, Nicolas Boissel, Maria Luigi Randi, Linda Resar, Martin Griesshammer, Jean‐Jacques Kiladjian   +8 more
wiley   +1 more source